Global Intra-uterine Contraceptive Devices (IUCD) Market, 2017-2024 - Increasing Demand for Generic and Biosimilar Drugs
Comunicato Precedente
Comunicato Successivo
In this region, global intra-uterine contraceptive devices market is projected to reach USD 4,851.2 million by 2024 from USD 3,684.1 million in 2016, at a CAGR of 3.5% in the forecast period 2017 to 2024.
The global intra-uterine contraceptive devices market is segmented on the basis of product type, end user, and geography.
The global intra-uterine contraceptive devices market is segmented into 2 product types, namely copper IUCD and hormonal IUCD.
On the basis of end users the market is segmented into hospitals, gynaecology clinics, and community healthcare. In 2017, the hospital segment is expected to dominate the market and is expected to continue this trend till 2024.
Market Overview
Drivers
Restraints
Opportunity
Challenges
Global intra-uterine contraceptive devices (IUCD) market competition by top players including:
Bayer AG dominated the IUCD market accounting largest market share followed by Teva Pharmaceuticals Industries Ltd., and
Mona Lisa N.V. along with others such as include:
Key Topics Covered:
1. Introduction
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. Global Injectable Drug Delivery Market, Regulatory
7. Global Injectable Drug Delivery Market, by Type
8. Global Injectable Drug Delivery Market, by Application
9. Global Injectable Drug Delivery Market, by Usage Pattern
10. Global Injectable Drug Delivery Market, by Mode of Administration
11. Global Injectable Drug Delivery Market, by End User
12. Global Injectable Drug Delivery Market, by Distribution Channel
13. Global Injectable Drug Delivery Market, by Geography
14. Global Injectable Drug Delivery Market, Company Share
15. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/v5l825/global_iucd
Media Contact:
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
